MetLife, Inc. (MET) Market Cap & Valuation Ratios
MetLife, Inc. (MET) has a market cap of $62.8B, a trailing P/E of 18.9 and a price-to-sales ratio of 0.8, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
METMetLife, Inc.Follow MET — free
—
Price chart with a free account
- Market cap
- 62.8B
- P/E TTM
- 18.9
- Dividend yield
- 2.3%
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Peers
insurance - life · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | P/B | ROE | Div. yield | Rev. growth |
|---|---|---|---|---|---|---|
| MET | 63 | 18.9 | 2.33 | 13% | 2.3% | +9% |
| AFL | 60 | 13.0 | 1.99 | 17% | 2.0% | +14% |
| PRU | 40 | 10.4 | 1.26 | 13% | 4.8% | +9% |
| UNM | 14 | 21.0 | 1.32 | 6% | 2.0% | +3% |
| GL | 12 | 10.3 | 1.93 | 21% | 0.8% | +5% |
| JXN | 8.8 | 153.2 | 0.89 | 1% | 2.7% | +15% |
| PRI | 8.4 | 11.0 | 3.35 | 33% | 1.6% | +9% |
| LNC | 7.6 | 3.4 | 0.67 | 23% | 4.5% | +8% |
| CNO | 5.0 | 18.4 | 1.92 | 11% | 1.3% | +6% |
| GNW | 3.4 | 16.8 | 0.39 | 2% | — | +2% |
| FG | 2.7 | 7.0 | 0.59 | 9% | 4.7% | +15% |
| Median of these 10 | 12.0 | 1.29 | 12% | 2.0% | +8% |
P/E 18.9 vs. a peer median of 12.0; P/B 2.33 vs. 1.29. MET's own P/E sits at the 79th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesHover or tap a dot for values.
MetLife, Inc. — questions
- What is MetLife, Inc.'s market cap?
- $62.8B.
- What is MetLife, Inc.'s P/E ratio?
- 18.9 on trailing twelve-month earnings to 2026-06-30.
- What is MetLife, Inc.'s price-to-sales ratio?
- 0.8.
Every figure on this page comes from MetLife, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.